Breast Cancer Prevention: Where Are We?

被引：2
作者：
Nangia, Julie R. [1 ]
Rimawi, Mothaffar F. [1 ]
机构：
[1] Baylor Coll Med, Dal L Duncan Comprehens Canc Ctr, 7200 Cambridge,7th Floor, Houston, TX 77030 USA
来源：
JCO ONCOLOGY PRACTICE | 2021年 / 17卷 / 12期
关键词：
RISK; MORTALITY; FOLATE; WOMEN; OBESITY; INDEX;
D O I：
10.1200/OP.21.00605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：720 / 722
页数：3
相关论文
共 50 条
  • [21] Firefighters and cancer: Where are we and where to now?
    Fritschi, Lin
    Glass, Deborah C.
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 71 (08) : 525 - 526
  • [22] Breast Density Where Are We Now?
    Kim, Eric
    Lewin, Alana A.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2024, 62 (04) : 593 - 605
  • [23] Nutrition in the Prevention of Breast Cancer: A Middle Eastern Perspective
    Naja, Farah
    Nasreddine, Lara
    Awada, Sara
    Ahmad, Raeda El Sayed
    Hwalla, Nahla
    FRONTIERS IN PUBLIC HEALTH, 2019, 7
  • [24] Contralateral prophylactic mastectomy in male breast cancer: where do we stand?
    Sciarra, Antonella
    Buonerba, Carlo
    Lorenzo, Giuseppe Di
    Scafuri, Luca
    FUTURE SCIENCE OA, 2021, 7 (08):
  • [25] Environmental pollutants, diet, physical activity, body size, and breast cancer - Where do we stand in research to identify opportunities for prevention?
    Brody, Julia Green
    Rudel, Ruthann A.
    Michels, Karin B.
    Moysich, Kirsten B.
    Bernstein, Leslie
    Attfield, Kathleen R.
    Gray, Sharon
    CANCER, 2007, 109 (12) : 2627 - 2634
  • [26] Genetic counseling for breast cancer risk: how did we get here and where are we going?
    Lang, Katherine A. F.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (06) : 541 - 551
  • [27] Prevention Therapy for Breast Cancer: How Can We Do Better?
    Wood, Marie E.
    Cuke, Melissa
    Bedrosian, Isabelle
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (07) : 1970 - 1972
  • [28] Lung cancer screening in Europe: where are we in 2021?
    van Meerbeeck, Jan P.
    Franck, Caro
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2407 - 2417
  • [29] Government drivers of breast cancer prevention: A spatiotemporal analysis based on the association between breast cancer and macro factors
    Bai, Xiaodan
    Zhang, Xiyu
    Shi, Hongping
    Geng, Guihong
    Wu, Bing
    Lai, Yongqiang
    Xiang, Wenjing
    Wang, Yanjie
    Cao, Yu
    Shi, Baoguo
    Li, Ye
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [30] Aspirin and Cancer Prevention and Treatment: Are We There Yet?
    Potter, John D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (09) : 1439 - 1440
12345